| Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 6.73K | $ 13.60K | $ 6.30K | $ 3.00K | - |
| Operating Income | $ -413.02K | $ -36.63K | $ -43.91K | $ -72.94K | $ -57.10K |
| EBITDA | $ -279.73K | $ -36.32K | $ -44.91K | $ -72.94K | $ -59.11K |
| Net Income | $ -412.97K | $ -36.63K | $ -43.44K | $ -66.51K | $ -59.11K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 1.01M | $ 894.00 | $ 15.12K | $ 68.36K | $ 131.47K |
| Total Debt | $ 734.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ 567.45K | $ -354.00 | $ -14.27K | $ -17.50K | $ -61.47K |
| Total Liabilities | $ 1.43M | $ 87.00K | $ 64.60K | $ 74.40K | $ 71.00K |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -873.66K | $ -38.22K | $ 8.77K | $ -43.98K | $ -122.48K |
| Operating Cash Flow | $ -649.41K | $ -38.22K | $ -41.14K | $ -43.98K | $ -122.48K |
| Investing Cash Flow | |||||
| Financing Cash Flow |
Antiaging Quantum Living Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.